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1. Enrichment analyses of the unfiltered set of genes curated in HD Crossroads 
For the analysis presented in the main text, a filtered set of genes from HD Crossroads was 
used. Filtering was performed using the Target Validation Score (TVS). Genes were only 
included with a corresponding TVS equal or larger than 3.0, i.e. for which a causal 
relationship has been deduced from experiments in a HD model, or which were indicated in 
an association or linkage study. In contrast, lower TVS can imply that a gene: has an altered 
pathway or functional activity in HD (TVS = 2.5); displays altered expression or cellular 
distribution in HD, or its corresponding protein binds to mutant Htt (TVS= 2.0); is active in 
HD-relevant brain regions or is linked to HD-associated biological mechanism (TVS=1.0); or 
is implicated in neurodegeneration based on genome-wide screens (TVS=0). As the inclusion 
of low-scoring genes may provide indication for additional disease-relevant mechanisms, 
enrichment analyses for GO categories, KEGG pathways and Pfam families were also carried 
out on the full list of genes from HD Crossroads. They include 805 genes downloaded from 
the HD Crossroads web-site (http://www.hdresearchcrossroads.org), as well as 162 genes 
that were provided directly by the curators of HD Crossroads. The same thresholds for 
significance and minimum number of genes were applied to these analyses as for those 
presented in our paper. Our results can be found in the Additional files 2-6. 
 
The lists of GO categories, KEGG pathways and Pfam families that were enriched were 
subsequently compared to the corresponding lists derived for the filtered set of genes (Figure 
S1).  We found that the vast majority of categories, pathways and protein families were 
enriched, irrespective of the filter for the TVS. In general, a larger number of significant 
categories, pathways and protein families were detected for the full list of genes from HD 
Crossroads. A smaller number of categories, pathways or protein families were enriched only 
for the filtered gene list.  Inspection of the GO categories, KEGG pathways and Pfam families 
uniquely found in either of the two lists revealed the following: A) Most of the results unique 
to the unfiltered list had a number of genes close to the minimum number required, i.e., close 
to the threshold selected for the list, e.g. 25 genes for GO categories; B) Results unique to the 
filtered list generally had a FDR close the threshold of 0.25. Since their statistical significance 
for enrichment decreased on the unfiltered gene list, they were filtered out.  
 
 
 
 
 
Figure S1: Comparison of enriched GO categories, KEGG pathways and Pfam protein families. 
Venn diagrams include the numbers of categories, pathways and protein families that were commonly 
or uniquely detected as enriched for the full list of genes (blue circles) and the filtered list of genes 
(orange circle) from HD Crossroads.  Thresholds used for the different enrichment analysis are also 
shown.  
 
 
 
 Below we list the most significant results that are unique to the enrichment analysis for the 
unfiltered gene set.  It appears that many genes in these categories are related to synaptic 
functions, but have (as yet) a low TVS, and thus, were excluded from our HD-relevant gene 
set.   
 
For GO biological processes, the most significant categories that were found only for the 
unfiltered list were:  
 regulation of synaptic transmission (N=27; FDR = 5.8 * 10-14) 
 regulation of neurological system process (N=27; FDR = 2.4 * 10-13) 
 neurotransmitter transport (N=29; FDR = 5.5 * 10-13) 
 regulation of transmission of nerve impulse (N=27; FDR = 6.0 * 10-13) 
 di-, tri-valent inorganic cation homeostasis (N=44; FDR = 4.8 * 10-12) 
 
For GO cellular compartment, the most significant categories that were found only for the 
unfiltered list were: 
 synapse (N=47; FDR = 1.9 * 10-10) 
 plasma membrane (N=271; FDR = 1.7 * 10-8)  
 integral to plasma membrane (N=114; FDR = 2.2 * 10-8)  
 neuron projection (N=32; FDR = 3.5 * 10-8)  
 intrinsic to plasma membrane (N=114; FDR = 6.6 * 10-8) 
 
For GO molecular functions, the most significant categories that were found only for the 
unfiltered list were: 
 amine binding (N=25; FDR = 4.6 * 10-10) 
 ligand-gated ion channel activity (N=27; FDR = 7.1 * 10-8) 
 ligand-gated channel activity (N=27; FDR = 7.1 * 10-8) 
 receptor signaling protein activity (N=30; FDR = 3.8 * 10-7) 
 signal transducer activity(N=182; FDR =  2.2 * 10-6) 
 
For KEGG, the most significant pathways that were found only for the unfiltered list were: 
 Neuroactive ligand-receptor interaction (N=80; FDR = 2.4 * 10-16) 
 Non-small cell lung cancer (N=20; FDR = 8.2 * 10-6) 
 Thyroid cancer (N=13; FDR = 4.7 * 10-5) 
 Chemokine signaling pathway (N=41; FDR = 1.8 * 10-4) 
 Prion diseases (N=13; FDR = 3.9 * 10-4) 
 
For Pfam, molecular functions, the most significant unique protein families were: 
 Sir2 family (N=7; FDR = 1.9* 10-7) 
 ATP P2X receptor (N=6; FDR = 1.5 * 10-6) 
 Sodium:neurotransmitter symporter family(N=9; FDR = 1.9 * 10-5) 
 Nine Cysteines Domain of family 3 GPCR (N=8; FDR = 2.6 * 10-5) 
 ATP synthase alpha/beta family, nucleotide-binding domain(N=5; FDR = 2.7 * 10-5) 
 
 
2.  Mapping of unfiltered gene set to chromosomal location with suggestive 
evidence for linkage with HD age of onset 
In addition to the enrichment analysis, we carried out the integration with chromosomal 
location also for the  unfiltered set of genes. Altogether, 79 genes from the unfiltered list were 
mapped to chromosomal locations, for which linkage with age of onset were suggested based 
on genome-wide scans by Li et al. (2003, HD MAPS study) and by Gayán et al. (2008). 40 
genes were found in the chromosomal location indicated by the HD-MAPS study, while 77 
genes were located in regions indicated by Gayán et al.  In the region of overlap (2q33-35, 
4p16, 5q31-32, 6q22-24), we could locate 38 genes from the unfiltered gene list (Table S1). 
Figure S2 displays the distributions of both filtered and unfiltered genes from HD Crossroads 
that are located in the chromosomal regions with suggestive evidence for linkage, with respect 
to the two studies. The full list of genes with locations in any chromosomal region indicated 
by the genome-wide linkage studies can be found in the Additional file 7.   
 
  
 
EntrezID Symbol 
         
TVS Chromosome  Band 
Region = 2q33-2q35 7341 SUMO1 3 2 q33.1 
 
9689 BZW1 3 2 q33.1 
HD-maps study: LOD =1.63 23451 SF3B1 3 2 q33.1 
(at 2q33) 841 CASP8 2.5 2 q33.1 
 
1385 CREB1 3.5 2 q33.3 
 Gayan et al study: LOD =3.39 7855 FZD5 3 2 q33.3 
 (at 2q35) 3300 DNAJB2 3 2 q35 
  8941 CDK5R2 3 2 q35 
  10109 ARPC2 3 2 q35 
Region = 4p16 6286 S100P 3 4 p16.1 
 
9948 WDR1 3 4 p16.1 
HD-MAPS  study: LOD =1.93 1816 DRD5 2 4 p16.1 
 
118 ADD1 3 4 p16.3 
Gayan et al study: LOD =1.49 3064 HTT 4 4 p16.3 
 
7469 WHSC2 3 4 p16.3 
  2868 GRK4 2 4 p16.3 
  10815 CPLX1 2 4 p16.3 
Region = 5q31-32 3308 HSPA4 3.5 5 q31.1 
 
6500 SKP1 3 5 q31.1 
HD-maps study: LOD =2.02 2107 ETF1 3 5 q31.2 
(at 5q31-32) 3313 HSPA9 3 5 q31.2 
 
7322 UBE2D2 3 5 q31.2 
 Gayan et al study: LOD =3.14 2676 GFRA3 2 5 q31.2 
 (at 5q32) 8841 HDAC3 4 5 q31.3 
  10915 TCERG1 3 5 q32 
  133522 PPARGC1B 3 5 q32 
Region = 6q22-24 2444 FRK 3 6 q22.1 
 
6206 RPS12 3 6 q23.2 
HD-maps study: LOD =2.28 9439 MED23 3 6 q23.2 
(at 6q23-24) 9038 TAAR5 2 6 q23.2 
  9287 TAAR2 2 6 q23.2 
Gayan et al study: LOD =2.48 9288 TAAR3 2 6 q23.2 
 (at 6q22) 83551 TAAR8 2 6 q23.2 
 
134860 TAAR9 2 6 q23.2 
 
134864 TAAR1 2 6 q23.2 
 
319100 TAAR6 2 6 q23.2 
  4217 MAP3K5 4 6 q23.3 
  2911 GRM1 3 6 q24.3 
 
Table S1: Candidate list of genetic modifiers. Table of genes from the unfiltered gene list 
that are located in chromosomal regions for which both genome-wide association studies 
suggest evidence of linkage with modified age of onset.  
 
 
 
  
Figure S2: Number of genes in a chromosomal location with suggestive linkage to HD 
age of onset. The Venn diagrams depict the distribution of genes located in chromosomal 
regions with suggestive evidence for linkage from the two studies.  
 
3. Assessment of potential bias of curated HD-relevant genes towards drug 
targets 
One of the main motivations behind the implementation of HD Crossroads is to provide a 
platform to select gene targets, whose activity can be manipulated to treat HD. Since small 
molecules (”drugs”) are currently the major vesicle for the therapeutic treatment of the 
disease, the set of genes included in HD Crossroads might be biased towards known drug 
targets. This tendency might not be intentional, but may simply result from the fact that drug 
targeted proteins can more readily be examined for their relevance to HD. To distinguish 
between the available evidence for relevance and the possibility of targeting a protein by 
small molecules, HD Crossroads assigns a Drugability Score (DS) in addition to a Target 
Validation Score (TVS) to all curated genes.   
To examine whether a potential bias exists in the database, we searched the list of HD-
relevant genes for known drug targets. A set of 1907 known drug targets (indexed by their 
Entrez Gene ID) was retrieved from the DrugBank (www.drugbank.ca). In total, 197 of the 
HD-relevant genes were also drug targets (28%). This number is considerably higher than 
what we would expect by chance (N=53, assuming the total number of genes in human to be 
25.000).     
We also analyzed the functional composition of these known drug targets. We and found that 
168 GO categories were significantly enriched in drug targets (FDR < 0.25; N ≥ 25). 
Subsequently, we compared this set of categories with the set of categories that we found to 
be enriched in HD-relevant genes.  Of 54 categories enriched in HD-relevant genes, 34 were 
also enriched in drug targets. Examples are: nucleotide binding (FDR= 2.6 *10 
-25
), kinase 
activity (FDR= 2.0 *10 
-20
), catalytic activity (FDR= 6.4 *10 
-178
), enzyme binding (FDR= 
6.5*10 
-3
) and transporter activity (FDR= 2.0 *10 
-2
).  Thus, the significance of these 
categories is likely to be influenced by the large number of drug targets in the set of HD–
relevant genes.    
For Pfam families, which were found to be enriched in HD-relevant genes, we found that only 
the protein kinases family was also enriched in drug targets (FDR= 4.9 *10 
-8
).  
Finally, we analyzed the correlation of TVS and DS, by comparing the distribution of DS for 
the set of genes with the same TVS (Figure S3). In general, the DS tends to increase with 
higher TVS. However, it should be noted that the majority of genes included in HD 
Crossroads have a low DS.  
  
 Figure S3: Distribution of Drugability scores. The pie charts depict the distribution of Drugability 
scores (ranging from 0.0 to 5.0) for genes with the same Target Validation scores.  
  
Figure S4: Distribution of HD-associated genes across molecular functions. A) The pie-
chart shows the distribution of HD-associated genes linked to a reduced set of molecular 
processes with a minimum number of 25 genes included. GO terms for molecular processes 
that are significantly enriched (FDR≤0.01) are highlighted in bold. GO terms set in red 
indicate a corresponding odds ratio ≥ 2.0. Note that the molecular functions are not exclusive, 
i.e., a gene can be assigned to several functions.  B) The bar plot displays odds ratios for 
enrichment by HD-associated genes in selected molecular functions.  
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